Earnings call uniQure reported Q1 2025 revenue of $1.6M, down from $8.5M YoY due to discontinued manufacturing operations. The company advanced AMT-130 for Huntington’s disease toward a BLA filing ...
Good day and thank you for standing by. Welcome to the UniCure Second Quarter twenty twenty five Earnings Conference Call. At this time, participants are in a listen only mode. After the speakers' ...
Biohaven (BHVN) shares fell about 25% pre-market amid concern that the FDA’s reversal on uniCure’s (QURE) Huntington’s gene therapy signals trouble for Biohaven’s troriluzole new drug application in ...
Learn about Unicure India Pvt. Ltd. in New Delhi, Delhi.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback